UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$463M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$360M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$345M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$265M |
| 5 |
ConocoPhillips
COP
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.03B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$293M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$239M |
| 5 |
UnitedHealth
UNH
|
+$206M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.86% |
| 2 | Healthcare | 14.95% |
| 3 | Financials | 12.1% |
| 4 | Consumer Discretionary | 10.74% |
| 5 | Communication Services | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVTA
1876
DELISTED
Avantax, Inc. Common Stock
AVTA
| $1.07M | ﹤0.01% |
55,201
+6,461
| +13% | +$130K |
|
1877
Emergent Biosolutions
EBS
$228M
| $1.07M | ﹤0.01% |
50,783
-1,806
| -3% | -$50.3K |
|
1878
CVR Energy
CVI
$3.28B
| $1.07M | ﹤0.01% |
36,775
-6,113
| -14% | -$193K |
|
1879
Urban Outfitters
URBN
$6.82B
| $1.06M | ﹤0.01% |
54,097
-26,745
| -33% | -$561K |
|
1880
Andersons Inc
ANDE
$2.23B
| $1.06M | ﹤0.01% |
34,256
-3,145
| -8% | -$109K |
|
1881
Malibu Boats
MBUU
$567M
| $1.06M | ﹤0.01% |
22,144
+1,500
| +7% | +$88.5K |
|
1882
Alignment Healthcare
ALHC
$2.86B
| $1.06M | ﹤0.01% |
89,692
-1,713
| -2% | -$25K |
|
|
KYNB
1883
Kyntra Bio
KYNB
$28.7M
| $1.06M | ﹤0.01% |
3,262
-241
| -7% | -$77.6K |
|
1884
MillerKnoll
MLKN
$1.63B
| $1.06M | ﹤0.01% |
67,998
-235,857
| -78% | -$6.48M |
|
|
CDMO
1885
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.06M | ﹤0.01% |
55,446
+474
| +0.9% | +$8.64K |
|
1886
Virgin Galactic
SPCE
$404M
| $1.06M | ﹤0.01% |
11,246
+658
| +6% | +$84.5K |
|
1887
Brinker International
EAT
$9.7B
| $1.06M | ﹤0.01% |
42,252
-4,875
| -10% | -$132K |
|
|
PRA
1888
DELISTED
ProAssurance
PRA
| $1.05M | ﹤0.01% |
54,063
-5,282
| -9% | -$116K |
|
1889
Sonic Automotive
SAH
$2.57B
| $1.05M | ﹤0.01% |
24,190
+4,421
| +22% | +$200K |
|
1890
Designer Brands
DBI
$333M
| $1.05M | ﹤0.01% |
68,261
-2,932
| -4% | -$46K |
|
1891
Perdoceo Education
PRDO
$2.02B
| $1.04M | ﹤0.01% |
101,170
-4,019
| -4% | -$48K |
|
1892
Syndax Pharmaceuticals
SNDX
$1.82B
| $1.04M | ﹤0.01% |
43,303
-2,954
| -6% | -$66.3K |
|
1893
Liberty Latin America Class C
LILAK
$1.67B
| $1.03M | ﹤0.01% |
184,834
-39,896
| -18% | -$257K |
|
1894
Phreesia
PHR
$766M
| $1.03M | ﹤0.01% |
40,548
| – | – |
|
|
INVX
1895
Innovex International
INVX
$2.01B
| $1.03M | ﹤0.01% |
52,918
+3,942
| +8% | +$91.4K |
|
|
TE
1896
T1 Energy
TE
$1.49B
| $1.03M | ﹤0.01% |
72,489
-10,181
| -12% | -$114K |
|
|
HAPN
1897
Happen Inc
HAPN
$2.24B
| $1.03M | ﹤0.01% |
93,393
+570
| +0.6% | +$7.67K |
|
|
VTLE
1898
DELISTED
Vital Energy
VTLE
| $1.03M | ﹤0.01% |
16,415
+4,258
| +35% | +$303K |
|
|
ZUO
1899
DELISTED
Zuora, Inc.
ZUO
| $1.03M | ﹤0.01% |
139,720
+14,106
| +11% | +$122K |
|
1900
Krispy Kreme
DNUT
$551M
| $1.03M | ﹤0.01% |
89,321
+5,619
| +7% | +$74K |
|
Similar funds
UBS AM's Q3 2022 Portfolio in Review
As of Q3 2022, UBS AM held 2,816 positions worth $178B, down 6.6% from $191B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
UBS AM's Q3 2022 filing shows 65 new, 702 increased, 1,679 reduced and 77 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M. The largest sale was Apple, an estimated $2.03B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q3 2022 buy was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M.
- UBS AM added most to Accenture in Q3 2022, an estimated $463M increase.
- UBS AM's biggest Q3 2022 reduction was Apple, cutting an estimated $2.03B.
- UBS AM fully exited Vanguard Russell 1000 ETF in Q3 2022, selling an estimated $93.3M.
- UBS AM's ten largest holdings make up 21% of its $178B portfolio in Q3 2022.
- UBS AM opened 65 new positions and closed 77 in Q3 2022.
- UBS AM's portfolio value fell 6.6% quarter-over-quarter to $178B.
Based on UBS AM's 13F filing for Q3 2022, filed 14 Nov 2022.